athenahealth, Inc. (NASDAQ:ATHN) Director Brandon H. Hull sold 800 shares of the business’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $132.97, for a total value of $106,376.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Brandon H. Hull also recently made the following trade(s):
- On Monday, November 20th, Brandon H. Hull sold 800 shares of athenahealth stock. The stock was sold at an average price of $130.00, for a total value of $104,000.00.
- On Friday, October 20th, Brandon H. Hull sold 800 shares of athenahealth stock. The stock was sold at an average price of $130.00, for a total value of $104,000.00.
athenahealth, Inc. (ATHN) traded down $0.07 during trading hours on Thursday, reaching $133.78. The company’s stock had a trading volume of 325,000 shares, compared to its average volume of 575,749. athenahealth, Inc. has a twelve month low of $90.11 and a twelve month high of $158.66. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.35. The company has a market capitalization of $5,356.37, a price-to-earnings ratio of 113.43, a PEG ratio of 5.02 and a beta of 1.57.
athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.06. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The business had revenue of $304.60 million during the quarter, compared to analyst estimates of $310.52 million. During the same quarter in the previous year, the company posted $0.60 earnings per share. athenahealth’s revenue for the quarter was up 10.1% on a year-over-year basis. equities analysts anticipate that athenahealth, Inc. will post 1.2 earnings per share for the current year.
Several analysts have recently weighed in on ATHN shares. Wells Fargo & Company reduced their price target on athenahealth from $190.00 to $155.00 and set an “outperform” rating on the stock in a report on Monday, October 23rd. Oppenheimer reiterated a “buy” rating and issued a $184.00 target price on shares of athenahealth in a report on Friday, October 20th. KeyCorp reiterated a “buy” rating and issued a $170.00 target price on shares of athenahealth in a report on Sunday, September 17th. TheStreet cut athenahealth from a “b-” rating to a “c+” rating in a report on Wednesday, October 11th. Finally, First Analysis upgraded athenahealth from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $125.00 to $127.00 in a report on Monday, October 23rd. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and eleven have assigned a buy rating to the stock. athenahealth has an average rating of “Hold” and an average price target of $143.22.
Large investors have recently added to or reduced their stakes in the business. Turner Investments LLC bought a new stake in athenahealth during the second quarter valued at about $105,000. Bessemer Group Inc. boosted its stake in shares of athenahealth by 13.7% in the second quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock worth $132,000 after acquiring an additional 113 shares during the period. The Manufacturers Life Insurance Company boosted its stake in shares of athenahealth by 7.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock worth $166,000 after acquiring an additional 84 shares during the period. Seven Bridges Advisors LLC boosted its stake in shares of athenahealth by 5.4% in the second quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock worth $183,000 after acquiring an additional 67 shares during the period. Finally, BNP Paribas Arbitrage SA boosted its stake in shares of athenahealth by 123.8% in the second quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock worth $189,000 after acquiring an additional 744 shares during the period.
TRADEMARK VIOLATION WARNING: “Insider Selling: athenahealth, Inc. (ATHN) Director Sells $106,376.00 in Stock” was originally reported by Transcript Daily and is the property of of Transcript Daily. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at https://transcriptdaily.com/2017/12/07/insider-selling-athenahealth-inc-athn-director-sells-106376-00-in-stock.html.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.